4//SEC Filing
BAKER BIOTECH CAPITAL II GP LLC 4
Accession 0001181431-05-019248
CIK 0001060736other
Filed
Mar 29, 7:00 PM ET
Accepted
Mar 30, 7:43 PM ET
Size
12.4 KB
Accession
0001181431-05-019248
Insider Transaction Report
Form 4
BAKER FELIX
Director10% Owner
Transactions
- Purchase
Common Stock
2005-03-29$4.81/sh+2,486$11,967→ 248,023 total(indirect: See Footnote) - Purchase
Common Stock
2005-03-28$4.90/sh+809$3,964→ 245,537 total(indirect: See Footnote) - Purchase
Common Stock
2005-03-29$4.90/sh+5,934$29,072→ 253,957 total(indirect: See Footnote)
BAKER JULIAN
Director10% Owner
Transactions
- Purchase
Common Stock
2005-03-28$4.90/sh+809$3,964→ 245,537 total(indirect: See Footnote) - Purchase
Common Stock
2005-03-29$4.81/sh+2,486$11,967→ 248,023 total(indirect: See Footnote) - Purchase
Common Stock
2005-03-29$4.90/sh+5,934$29,072→ 253,957 total(indirect: See Footnote)
BAKER BIOTECH CAPITAL II GP LLC
Director10% Owner
Transactions
- Purchase
Common Stock
2005-03-29$4.90/sh+5,934$29,072→ 253,957 total(indirect: See Footnote) - Purchase
Common Stock
2005-03-28$4.90/sh+809$3,964→ 245,537 total(indirect: See Footnote) - Purchase
Common Stock
2005-03-29$4.81/sh+2,486$11,967→ 248,023 total(indirect: See Footnote)
Footnotes (3)
- [F1]In addition to Baker Biotech Capital II (GP), LLC, this Form 4 is being filed jointly by Julian C. Baker and Felix J. Baker, each of whom has the same business address as Baker Biotech Capital II (GP), LLC and may be deemed to have a pecuniary interest in securities owned by it. Because of certain relationships with other security holders of the Issuer, the Reporting Persons have filed on Schedule 13D as if they were a member of a group with such shareholders. (Continued in footnote 2.)
- [F2]However, the Reporting Persons disclaim that they and any other person or persons, including those persons with whom the Reporting Persons have filed a Schedule 13D in fact constitute a "group" for purposes of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, or Rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein. Felix J. Baker is a director of the Issuer.
- [F3]Represents shares of common stock owned directly by Baker Biotech Fund II, L.P., a limited partnership the sole general partner of which is Baker Biotech Capital II, L.P., a limited partnership the sole general partner of which is Baker Biotech Capital II (GP), LLC. Felix J. Baker and Julian C. Baker are the controlling members of Baker Biotech Capital II (GP), LLC.
Documents
Issuer
SEATTLE GENETICS INC /WA
CIK 0001060736
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001244386
Filing Metadata
- Form type
- 4
- Filed
- Mar 29, 7:00 PM ET
- Accepted
- Mar 30, 7:43 PM ET
- Size
- 12.4 KB